Venus Remedies Income Statement

Quarterly

Yearly

home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
202120222023
EBITDA73700
EBIT62370
Earning Per Share503020
Expenses494537495
Net Profit624127
Net Profit Margin1175
Operating Profit Margin131213
Profit Before Tax493638
Dividends Per Share000
Operation Revenue568607566

Peer Comparison (in ₹.Cr.)

CompanyYearEBITEBITDANet ProfitNet WorthProfit Before Tax
20230080.62NA86.80
202300377.40NA868.45
202300447.69NA716.49
2023004,470.30NA6,011.50
2023008,560.84NA9,408.43
The EBITDA of Venus Remedies is 0 as of 6/6/2023
home icon
The current prices are delayed, login to your account to see live prices.
LOGIN
20182019202020212022
Operating Activities31457813241
Investing Activities-11-11-556-17
Financing Activities-39-35-73-162-9
Others00000
Net Cash Flow-20-1-02615

Peer Comparison (in ₹.Cr.)

CompanyYearOperating ActivitiesInvesting ActivitiesFinancing ActivitiesNet Cash Flow
2022-17.7518.85-5.82-4.72
20201,392.41-783.52-444.66164.23
20201,468.841,106.99-890.581,685.25
20163,262.60-2,039.40-1,700.10-476.90
20183,907.15-3,370.81-1,539.26-1,002.92
The cash flow from Operating Activities of Venus Remedies is 41 as of 6/6/2023